Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (221-230 of 645) with videos related to

Pageof 65
Sort By:
Expert Review of Clinical Pharmacology|April 27, 2022
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPDMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Current Research in Pharmacology and Drug Discovery|March 4, 2022
The future of inhalation therapy in chronic obstructive pulmonary diseaseMario Cazzola, Josuel Ora, Luigino Calzetta, et al.
British Journal of Pharmacology|October 20, 2023
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disordersLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Expert Review of Clinical Pharmacology|September 5, 2020
Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findingsPaola Rogliani, Beatrice Ludovica Ritondo, Mariachiara Gabriele, et al.
Pulmonary Pharmacology & Therapeutics|August 3, 2016
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysisPaola Rogliani, Luigino Calzetta, Francesco Cavalli, et al.
Expert Review of Respiratory Medicine|May 25, 2021
Step-up and step-down approaches in the treatment of asthmaMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
Expert Opinion on Pharmacotherapy|May 16, 2022
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?Mario Cazzola, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Pharmacotherapy|May 9, 2017
An update on the pharmacotherapeutic management of lower respiratory tract infectionsMario Cazzola, Paola Rogliani, Stefano Aliberti, et al.
Pulmonary Pharmacology & Therapeutics|December 14, 2017
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysisMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Opinion on Drug Safety|March 6, 2018
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPDMaria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, et al.
Pageof 65

Showing results (221-230 of 645) with videos related to

Sort By:
Pageof 65
Expert Review of Clinical Pharmacology|April 27, 2022
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPDMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Current Research in Pharmacology and Drug Discovery|March 4, 2022
The future of inhalation therapy in chronic obstructive pulmonary diseaseMario Cazzola, Josuel Ora, Luigino Calzetta, et al.
British Journal of Pharmacology|October 20, 2023
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disordersLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Expert Review of Clinical Pharmacology|September 5, 2020
Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findingsPaola Rogliani, Beatrice Ludovica Ritondo, Mariachiara Gabriele, et al.
Pulmonary Pharmacology & Therapeutics|August 3, 2016
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysisPaola Rogliani, Luigino Calzetta, Francesco Cavalli, et al.
Expert Review of Respiratory Medicine|May 25, 2021
Step-up and step-down approaches in the treatment of asthmaMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
Expert Opinion on Pharmacotherapy|May 16, 2022
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?Mario Cazzola, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Pharmacotherapy|May 9, 2017
An update on the pharmacotherapeutic management of lower respiratory tract infectionsMario Cazzola, Paola Rogliani, Stefano Aliberti, et al.
Pulmonary Pharmacology & Therapeutics|December 14, 2017
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysisMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Opinion on Drug Safety|March 6, 2018
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPDMaria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, et al.
Pageof 65